Gene · 5792
Papers2,345
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,345
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetics of female and male reproductive traits and their relationship with health, longevity and consequences for offspring. | Nat Aging | 2024 | 39672892 | PubTator, text mining | PubMed |
| The Lotus corniculatus MYB5 functions as a master regulator in proanthocyanidin biosynthesis and bioengineering. | Plant Cell Rep | 2024 | 39557697 | PubTator, text mining | PubMed |
| Structure-based screening of FDA-approved drugs and molecular dynamics simulation to identify potential leukocyte antigen related protein (PTP-LAR) inhibitors. | Comput Biol Chem | 2024 | 39488935 | PubTator, text mining | PubMed |
| Primary care perspectives on leptin and adiponectin in north Indian families with metabolic syndrome. | J Family Med Prim Care | 2024 | 39464955 | PubTator, text mining | PubMed |
| Unveiling the Molecular Mechanisms of Browning in Camellia hainanica Callus through Transcriptomic and Metabolomic Analysis. | Int J Mol Sci | 2024 | 39456802 | PubTator, text mining | PubMed |
| Refractory Autoimmune Thrombocytopenia in an Infant with a De Novo TLR7 Gain-of-Function Variant. | J Clin Immunol | 2024 | 39433707 | PubTator, text mining | PubMed |
| Astrocytes originated from neural stem cells drive the regenerative remodeling of pathologic CSPGs in spinal cord injury. | Stem Cell Reports | 2024 | 39303705 | PubTator, text mining | PubMed |
| Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Cancer. | ACS Nano | 2024 | 39287044 | PubTator, text mining | PubMed |
| KLF3 impacts insulin sensitivity and glucose uptake in skeletal muscle. | Am J Physiol Cell Physiol | 2024 | 39250818 | PubTator, text mining | PubMed |
| Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer. | Cancer Lett | 2024 | 39244005 | PubTator, text mining | PubMed |
| [Biological characteristics of triple negative breast cancer with low expression of HER2]. | Zhonghua Bing Li Xue Za Zhi | 2024 | 39231741 | PubTator, text mining | PubMed |
| HP-YOLOv8: High-Precision Small Object Detection Algorithm for Remote Sensing Images. | Sensors (Basel) | 2024 | 39123905 | PubTator, text mining | PubMed |
| How the Degree of Anthropomorphism of Human-like Robots Affects Users' Perceptual and Emotional Processing: Evidence from an EEG Study. | Sensors (Basel) | 2024 | 39123856 | PubTator, text mining | PubMed |
| Aptamer-Based Enforced Phosphatase-Recruiting Chimeras Inhibit Receptor Tyrosine Kinase Signal Transduction. | J Am Chem Soc | 2024 | 39087949 | PubTator, text mining | PubMed |
| Combined Metabolomics and Transcriptomics Analysis of the Distribution of Flavonoids in the Fibrous Root and Taproot of Polygonatum kingianum Coll.et Hemsl. | Genes (Basel) | 2024 | 39062607 | PubTator, text mining | PubMed |
| Author Correction: Specification of neural circuit architecture shaped by context-dependent patterned LAR-RPTP microexons. | Nat Commun | 2024 | 39043694 | PubTator, text mining | PubMed |
| The tyrosine phosphatases LAR and PTPRδ act as receptors of the nidogen-tetanus toxin complex. | EMBO J | 2024 | 38977849 | PubTator, text mining | PubMed |
| A Reversible Neural Stem Cell Quiescence and Activation Culture System for Metabolic Study. | Cell Transplant | 2024 | 38877676 | PubTator, text mining | PubMed |
| Correction for Yim et al., Slitrks control excitatory and inhibitory synapse formation with LAR receptor protein tyrosine phosphatases. | Proc Natl Acad Sci U S A | 2024 | 38870062 | PubTator, text mining | PubMed |
| Phase 2 study of neoadjuvant enzalutamide and paclitaxel for luminal androgen receptor-enriched TNBC: Trial results and insights into "ARness". | Cell Rep Med | 2024 | 38838676 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5792/papers?page=7